Mesenchymal stem cells in the treatment of osteonecrosis of the jaw

Medication-related osteonecrosis of the jaw (MRONJ) has recently associated to the increase in antiresorptive and anti-angiogenic drugs prescriptions in the treatment of oncologic and osteoporotic patients. The physiopathogenesis of MRONJ remains unclear and available treatments are unsatisfactory....

Descripción completa

Detalles Bibliográficos
Autores principales: Nifosì, Gianfilippo, Nifosì, Lorenzo, Nifosì, Antonio Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Oral and Maxillofacial Surgeons 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084742/
https://www.ncbi.nlm.nih.gov/pubmed/33911038
http://dx.doi.org/10.5125/jkaoms.2021.47.2.65

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084742/
https://www.ncbi.nlm.nih.gov/pubmed/33911038
http://dx.doi.org/10.5125/jkaoms.2021.47.2.65

Ejemplares similares